Back to Companies
Apogee Therapeutics, Inc.
APGENasdaqCIK: 0001974640
Apogee Therapeutics, Inc. (APGE) shows 48 recent insider filings from 9 insiders, with all of them on the sell side. With $0 in purchases and $164.2M in sales, the recent tape is heavily weighted toward selling (net sales of $164.2M). Shah Nimish P is the most active by dollar volume, and the single largest transaction was $239.0M by Shah Nimish P. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$533.7M
Purchases
$0
Sales
$164.2M
Unique Insiders
9
Recent Insider Trades
48 loaded
| Sep 3 | APGE Apogee Therapeutics, Inc. | JONES WILLIAM A JR | Insider | Disposed | $1.7M |
| Sep 3 | APGE Apogee Therapeutics, Inc. | McKenna Mark C. | Insider | Disposed | $5.2M |
| Sep 3 | APGE Apogee Therapeutics, Inc. | Bollinger Lisa | Insider | Disposed | $2.5M |
| Sep 3 | APGE Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Insider | Disposed | $45.5M |
| Sep 3 | APGE Apogee Therapeutics, Inc. | Shah Nimish P | Insider | Disposed | $239.0M |
| Sep 3 | APGE Apogee Therapeutics, Inc. | Fox Jennifer A. | Insider | Disposed | $1.7M |
| Sep 3 | APGE Apogee Therapeutics, Inc. | Fairmount Funds Management LLC | Director | Disposed | $2.5M |
| Sep 3 | APGE Apogee Therapeutics, Inc. | Henderson Jane | Insider | Disposed | $16.5M |
| Sep 3 | APGE Apogee Therapeutics, Inc. | Dambkowski Carl | Insider | Disposed | $15.2M |
| Aug 11 | APGE Apogee Therapeutics, Inc. | Fairmount Funds Management LLC | Director | Exercise | $2.0M |
| Aug 7 | APGE Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | Sell | $737.9K |
| Jul 24 | APGE Apogee Therapeutics, Inc. | Henderson Jane | Chief Financial Officer | Gift | $0 |
| Jul 16 | APGE Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | Gift | $0 |
| Jul 10 | APGE Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Chief Executive Officer, Director | Sell | $2.7M |
| Jul 2 | APGE Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | Sell | $730.1K |
| Jun 24 | APGE Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Chief Executive Officer, Director | Sell | $10.6M |
| Jun 24 | APGE Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | Sell | $3.5M |
| Jun 12 | APGE Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Chief Executive Officer, Director | Sell | $1.7M |
| Jun 11 | APGE Apogee Therapeutics, Inc. | Fairmount Funds Management LLC | Director | Award | $650.8K |
| Jun 11 | APGE Apogee Therapeutics, Inc. | Shah Nimish P | Director | Award | $650.8K |
| Jun 11 | APGE Apogee Therapeutics, Inc. | McKenna Mark C. | Director | Award | $650.8K |
| Jun 11 | APGE Apogee Therapeutics, Inc. | JONES WILLIAM A JR | Director | Award | $650.8K |
| Jun 11 | APGE Apogee Therapeutics, Inc. | Bollinger Lisa | Director | Award | $650.8K |
| Jun 11 | APGE Apogee Therapeutics, Inc. | Fox Jennifer A. | Director | Award | $650.8K |
| Jun 5 | APGE Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | Sell | $432.9K |
| May 15 | APGE Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Chief Executive Officer, Director | Sell | $1.6M |
| May 8 | APGE Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | Sell | $462.8K |
| May 4 | APGE Apogee Therapeutics, Inc. | Henderson Jane | Chief Financial Officer | Sell | $164.1K |
| Apr 17 | APGE Apogee Therapeutics, Inc. | Henderson Jane | Chief Financial Officer | Sell | $180.0K |
| Apr 20 | APGE Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Chief Executive Officer, Director | Exercise | $137.2K |
| Apr 10 | APGE Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Chief Executive Officer, Director | Sell | $1.7M |
| Mar 4 | APGE Apogee Therapeutics, Inc. | Henderson Jane | Chief Financial Officer | Sell | $140.4K |
| Feb 4 | APGE Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | Sell | $361.9K |
| Feb 4 | APGE Apogee Therapeutics, Inc. | Henderson Jane | Chief Financial Officer | Sell | $131.6K |
| Jan 22 | APGE Apogee Therapeutics, Inc. | Fairmount Funds Management LLC | Director | Sell | $133.5M |
| Jan 16 | APGE Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Chief Executive Officer, Director | Sell | $1.6M |
| Jan 9 | APGE Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | Sell | $1.5M |
| Jan 6 | APGE Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Chief Executive Officer, Director | Award | $19.2M |
| Jan 6 | APGE Apogee Therapeutics, Inc. | Henderson Jane | Chief Financial Officer | Sell | $609.1K |
| Jan 6 | APGE Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | Award | $6.3M |
| Dec 23 | APGE Apogee Therapeutics, Inc. | Henderson Jane | Chief Financial Officer | Sell | $120.0K |
| Nov 28 | APGE Apogee Therapeutics, Inc. | Henderson Jane | Chief Financial Officer | Sell | $105.0K |
| Nov 13 | APGE Apogee Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Chief Executive Officer, Director | Sell | $1.3M |
| Nov 13 | APGE Apogee Therapeutics, Inc. | Henderson Jane | Chief Financial Officer | Sell | $60.0K |
| Oct 15 | APGE Apogee Therapeutics, Inc. | Shah Nimish P | Insider | Other | $0 |
| Oct 3 | APGE Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | Sell | $203.4K |
| Sep 5 | APGE Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | Sell | $103.2K |
| Aug 8 | APGE Apogee Therapeutics, Inc. | Dambkowski Carl | Chief Medical Officer | Sell | $103.0K |
48 filings